Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents?

Toxicology and Applied Pharmacology
R A RothP E Ganey

Abstract

Why certain individuals are more susceptible than others to harmful effects of chemical exposure remains incompletely understood. One understudied but potentially important determinant of susceptibility is concurrent or preexisting inflammation that may influence the pathogenic outcome of chemical exposure. Endotoxin from gram-negative bacteria is a potent inducer of inflammation. We are all exposed to endotoxin, and such exposure varies considerably among individuals depending on environment, bacterial infection, and conditions that affect its translocation from the lumen of the gastrointestinal tract into the circulation. Mammals have a vigorous response to endotoxin that includes recruitment and activation of inflammatory cells and release of many soluble mediators that affect cellular homeostasis. These and other results have led to the hypothesis that altered tissue homeostasis initiated by small, otherwise nontoxic doses of xenobiotic agents can progress to overt toxicity in the presence of inflammatory factors generated by concurrent endotoxin exposure. This hypothesis is supported by studies in animals, in which considerable evidence has accumulated indicating that endotoxin exposure can influence the magnitude of respo...Continue Reading

Citations

Jul 23, 2002·Journal of Toxicology and Environmental Health. Part a·Ramez LabibMohamed S Abdel-Rahman
Jan 11, 2003·Journal of Toxicology and Environmental Health. Part a·Ramez LabibRita Turkall
Aug 10, 2007·Journal of Toxicology and Environmental Health. Part a·Glen A FoxG Douglas Campbell
Dec 3, 2009·Journal of Toxicology and Environmental Health. Part a·Jane F MaddoxPatricia E Ganey
Jun 26, 2012·Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment·K ShaleP Venter
May 30, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Steven B YeeRobert A Roth
Mar 4, 2005·Clinical and Experimental Pharmacology & Physiology·Adel R A Abd-AllahOthman A Al-Shabanah
Oct 7, 2009·Pharmacological Reviews·Xiaomin DengRobert A Roth
Mar 28, 2006·Environmental Health : a Global Access Science Source·Ian StewartGlen R Shaw
Apr 25, 2014·International Journal of Molecular Sciences·Dolores B Njoku
Mar 30, 2013·Canadian Journal of Physiology and Pharmacology·Stephanie L MacAllisterPeter O'Brien
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·Michael J Liguori, Jeffrey F Waring
Jul 19, 2006·Journal of Veterinary Pharmacology and Therapeutics·A RahalV Ahuja
Jul 6, 2011·Critical Reviews in Toxicology·Robert A Roth, Patricia E Ganey
Sep 17, 2003·The Journal of Toxicological Sciences·Urs A Boelsterli
May 14, 2016·Cell Death & Disease·P K BarmanB Ravindran
Jul 20, 2010·Human & Experimental Toxicology·Periasamy SrinivasanMing-Yie Liu
Nov 4, 2004·Chemico-biological Interactions·Patricia E GaneyRobert A Roth
Nov 4, 2004·Chemico-biological Interactions·Jacintha M ShentonJack P Uetrecht
Feb 26, 2008·Toxicology and Applied Pharmacology·Shahrzad TafazoliPeter J O'Brien
Feb 1, 2005·Environmental Toxicology and Pharmacology·Anuradha RebbapragadaGeneva M Omann
Jun 19, 2004·International Journal of Toxicology·Thomas VisalliMohamed S Abdel-Rahman
Aug 23, 2003·International Journal of Toxicology·Ramez LabibMohamed S Abdel-Rahman
Sep 13, 2012·Toxicologic Pathology·Sherry J MorganLaura Conour
Jun 15, 2011·Toxicology and Industrial Health·I SáE M Cunha
Sep 13, 2017·International Journal of Molecular Sciences·Marcial SebodeAnsgar W Lohse
Jun 29, 2005·International Journal of Toxicology·Thomas VisalliMohamed S Abdel-Rahman
Oct 22, 2014·Journal of Applied Toxicology : JAT·Yijing SuLuyong Zhang
Jan 1, 2005·Toxicology Mechanisms and Methods·Thomas VisalliMohamed S Abdel-Rahman
May 12, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·James Pestka, Hui-Ren Zhou
Jul 19, 2006·Journal of Veterinary Pharmacology and Therapeutics·M Ismail
Aug 19, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·Francis F TukovRobert A Roth
Jan 21, 2017·The Journal of Pharmacology and Experimental Therapeutics·Robert A RothPatricia E Ganey
Jul 9, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Pamela Bachour-El AzziAndré Guillouzo
Aug 2, 2003·The Journal of Pharmacology and Experimental Therapeutics·James P LuyendykRobert A Roth
Sep 5, 2003·The Journal of Pharmacology and Experimental Therapeutics·Robert A RothPatricia E Ganey
Mar 30, 2006·The Journal of Pharmacology and Experimental Therapeutics·Sree D PanugantiCraig K Svensson
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·John P BuchweitzRobert A Roth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved